| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
20,720,000 |
| Market
Cap: |
195.80(K) |
| Last
Volume: |
17,571 |
Avg
Vol: |
17,442 |
| 52
Week Range: |
$0.00945 - $0.00945 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile PharmaCyte Biotech is a biotechnology company focused on developing cellular therapies for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box®. Co. is developing therapies for solid tumor cancers involving the encapsulation of live cells placed in the body to enable the activation of cancer-killing drugs to the source of the cancer. Co. is also developing a therapy for Type 1 diabetes and insulin-dependent Type 2 diabetes based upon the encapsulation of a human liver cell line to produce, store and secrete insulin at levels in proportion to the levels of blood sugar in the human body.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
160,000 |
160,000 |
160,000 |
160,000 |
| Total Buy Value |
$128,708 |
$128,708 |
$128,708 |
$128,708 |
| Total People Bought |
2 |
2 |
2 |
2 |
| Total Buy Transactions |
6 |
6 |
6 |
6 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2025-10-11 |
2025-07-10 |
2025-01-09 |
2024-01-10 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Silverman Joshua |
CEO and President |
• • – |
2026-01-07 |
4 |
B |
$0.83 |
$33,316 |
D/D |
40,000 |
416,250 |
2.81 |
- |
|
| Schechter Jonathan |
Director |
– • – |
2026-01-07 |
4 |
B |
$0.84 |
$16,872 |
D/D |
20,000 |
192,500 |
2.39 |
- |
|
| Silverman Joshua |
CEO and President |
• • – |
2026-01-06 |
4 |
B |
$0.79 |
$23,667 |
D/D |
30,000 |
376,250 |
2.81 |
- |
|
| Schechter Jonathan |
Director |
– • – |
2026-01-06 |
4 |
B |
$0.79 |
$15,808 |
D/D |
20,000 |
172,500 |
2.39 |
- |
|
| Silverman Joshua |
CEO and President |
• • – |
2026-01-05 |
4 |
B |
$0.78 |
$23,493 |
D/D |
30,000 |
346,250 |
2.81 |
- |
|
| Schechter Jonathan |
Director |
– • – |
2026-01-05 |
4 |
B |
$0.78 |
$15,552 |
D/D |
20,000 |
152,500 |
2.39 |
- |
|
| Walker Wayne Remell |
Director |
– • – |
2025-12-12 |
4 |
D |
$1.02 |
$17,213 |
D/D |
(16,875) |
20,625 |
|
- |
|
| Walker Wayne Remell |
Director |
– • – |
2025-12-12 |
4 |
A |
$0.00 |
$0 |
D/D |
37,500 |
37,500 |
|
- |
|
| Abecassis Michael M |
Director |
– • – |
2025-12-12 |
4 |
D |
$1.02 |
$17,213 |
D/D |
(16,875) |
22,292 |
|
- |
|
| Abecassis Michael M |
Director |
– • – |
2025-12-12 |
4 |
A |
$0.00 |
$0 |
D/D |
37,500 |
39,167 |
|
- |
|
| Weinstein Robert |
Director |
– • – |
2025-12-12 |
4 |
D |
$1.02 |
$34,425 |
D/D |
(33,750) |
41,250 |
|
- |
|
| Weinstein Robert |
Director |
– • – |
2025-12-12 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
75,000 |
|
- |
|
| Schechter Jonathan |
Director |
– • – |
2025-12-12 |
4 |
D |
$1.02 |
$68,850 |
D/D |
(67,500) |
132,500 |
|
- |
|
| Schechter Jonathan |
Director |
– • – |
2025-12-12 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
200,000 |
|
- |
|
| Silverman Joshua |
CEO and President |
• • – |
2025-12-12 |
4 |
D |
$1.02 |
$263,925 |
D/D |
(258,750) |
316,250 |
|
- |
|
| Silverman Joshua |
CEO and President |
• • – |
2025-12-12 |
4 |
A |
$0.00 |
$0 |
D/D |
575,000 |
575,000 |
|
- |
|
| Allen Daniel |
Director |
– • – |
2022-08-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
260,000 |
|
- |
|
| Schechter Jonathan |
Director |
– • – |
2022-08-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
50,000 |
|
- |
|
| Silverman Joshua |
Director |
– • – |
2022-08-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
50,000 |
|
- |
|
| Farb Daniel Stuart |
Director |
– • – |
2022-08-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
714,570 |
|
- |
|
| Loehr Matthias |
Director |
– • – |
2022-03-31 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,004 |
|
- |
|
| Yuen Thomas C K |
Director |
– • – |
2021-08-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,667 |
|
- |
|
| Waggoner Kenneth |
Chairman, CEO, Pres and GCOffi |
• • – |
2021-08-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
20,600 |
|
- |
|
| Abecassis Michael M |
Director |
– • – |
2021-08-10 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
800 |
|
- |
|
| Abecassis Michael M |
Director |
– • – |
2021-08-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,667 |
|
- |
|
27 Records found
|
|
Page 1 of 2 |
|
|
